Technology areas: Biotechnology & Pharmaceuticals • Semiconductors, Circuits & Optics
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
The University of Idaho currently has 3 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 3 distinct examiners, which suggests that the company is engaging with a variety of individual perspectives at the USPTO. The presence of 3 distinct art units indicates that these applications span several different technical classifications within the broader Biotechnology & Pharmaceuticals field.
The busiest examiner for the company is CHARIOUI, MOHAMED, who is currently handling 1 busiest examiner pending action. This means that the 3 pending office actions are spread thinly, with no single examiner managing more than 1 of the current cases. This lack of examiner concentration may require the company to adapt to 3 different sets of prosecution styles simultaneously.
From a practitioner's perspective, the diversity shown by the 3 distinct art units and 3 distinct examiners suggests a decentralized prosecution environment. Each of the 3 pending office actions likely requires a tailored approach, as the data does not show any clustering of cases under CHARIOUI, MOHAMED beyond the 1 busiest examiner pending action. The strategy must account for the unique requirements of each of the 3 distinct art units involved.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHARIOUI, MOHAMED | 1 | 81.2% | +12.7% |
| HORLICK, KENNETH R | 1 | 79.0% | +15.3% |
| GRASER, JENNIFER E | 1 | 76.8% | +23.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18697707 | DETECTION OF BEHAVIOR ANOMALIES IN CONTROL SYSTEMS AND RELATED SYSTEMS, METHODS, AND DEVICES | CHARIOUI, MOHAMED | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18329816 | COLDWATER DISEASE VACCINE COMPRISING AN ATTENUATED FLAVOBACTERIUM PSYCHROPHILUM STRAIN | GRASER, JENNIFER E | 132d overdue |
| 18473769 | CARBON COATED MAGNETIC PARTICLES AND METHODS FOR MAKING AND USING | HORLICK, KENNETH R | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18329816 | COLDWATER DISEASE VACCINE COMPRISING AN ATTENUATED FLAVOBACTERIUM PSYCHROPHILUM STRAIN | GRASER, JENNIFER E | 132d overdue |
| 18697707 | DETECTION OF BEHAVIOR ANOMALIES IN CONTROL SYSTEMS AND RELATED SYSTEMS, METHODS, AND DEVICES | CHARIOUI, MOHAMED | — |
| 18473769 | CARBON COATED MAGNETIC PARTICLES AND METHODS FOR MAKING AND USING | HORLICK, KENNETH R | — |
| Art Unit | Apps |
|---|---|
| 2857 | 1 |
| 1681 | 1 |
| 1645 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18697707 | DETECTION OF BEHAVIOR ANOMALIES IN CONTROL SYSTEMS AND RELATED SYSTEMS, METHODS, AND DEVICES | CHARIOUI, MOHAMED | 2857 | §103 | Non-Final OA | — | Pending | Apr 01, 2024 |
| 18473769 | CARBON COATED MAGNETIC PARTICLES AND METHODS FOR MAKING AND USING | HORLICK, KENNETH R | 1681 | §102§103§112 | Non-Final OA | — | Pending | Sep 25, 2023 |
| 18329816 | COLDWATER DISEASE VACCINE COMPRISING AN ATTENUATED FLAVOBACTERIUM PSYCHROPHILUM STRAIN | GRASER, JENNIFER E | 1645 | §102§112 | Non-Final OA | 132d overdue | Pending | Jun 06, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversity of Idaho has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Mohamed Charioui has the most, with 1 of University of Idaho's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
